Cinema projector maker has announced another innovation to help theatre owners get their businesses back on track while ensuring audiences remain safe; a line of commercial UV disinfection products with patented far-UVC light technology.
CounterAct, which is due to go into production in January 2021, uses Care222 excimer lamps from Christie’s parent company Ushio that emit far-UVC 222nm light. They say the lamps “continuously and significantly reduce pathogens, like coronaviruses, that may also be used while people are present, when used in accordance with specified parameters”.
Source: The Hollywood Reporter